Cara Therapeutics | CARA - Ebitda





Ebitda Changement Date
Acadia Pharmaceuticals USD 20.31M 15.44M 2025-12
Alterity Therapeutics Limited AUD -7.72M 2.99M 2023-06
Cara Therapeutics USD -2.39M 3.16M 2025-03
Cassava Sciences USD -11.73M 33.44M 2025-09
Chugai Pharma JPY 158.77B 10.24B 2026-03
Cipla INR 9.55B 3B 2026-03
Clal Biotechnology ILS -5.3M 2.09M 2022-12
Compugen USD -9.02M 1.12M 2026-03
CSL USD 3.13B 1.17B 2025-12
Grifols EUR 482.04M 7.04M 2025-09
Halozyme Therapeutics USD 219.57M 197.66M 2026-03
J&J USD 7.19B 2.32B 2025-12
Neurocrine Biosciences USD 193.3M 25.1M 2026-03
Pacira USD 40.24M 1.53M 2026-03
Pfizer USD 5.99B 5.23B 2026-03
RedHill Biopharma USD 2.69M 108.46M 2023-06
Supernus Pharmaceuticals USD 29.23M 19.27M 2026-03
Vanda Pharmaceuticals USD -8.31M 2.37M 2024-12